# OnCo record nct07058012 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07058012/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07058012", "NCT07058012" ;
  schema:name "A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal"@en ;
  schema:alternateName "EMPIRE"@en ;
  schema:description "A phase 2 trial of cemiplimab, fianlimab and REGN7075 in colorectal cancer, run by NSABP Foundation Inc, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07058012/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07058012> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest", "colorectal-deep-dive" ;
  onco:phase "2" ;
  onco:cancers <https://onco.cc/cancers/rectal-cancer/>, <https://onco.cc/cancers/colon-cancer/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/>, <https://onco.cc/technologies/mrd-testing/> ;
  onco:drugs <https://onco.cc/drugs/cemiplimab/>, <https://onco.cc/drugs/fianlimab/>, <https://onco.cc/drugs/regn7075/> ;
  onco:companies <https://onco.cc/companies/regeneron/> .